Rituxan (Rituximab) is a unique therapy that works by selectively depleting CD20+ B-cells. B-cells, and their role in cancer and autoimmune diseases, have been ...
The WaldenstromÂ’s Macroglobulinemia program at the Dana-Farber Cancer Institute, a Harvard Medical School affiliate, has spearheaded national and international ...
Extensive cancer website offering unbiased support and information regarding all types of cancer and chemotherapy options. Visitors have told us our website is ...
Home Contributors Glossary Subscribe Bioasis Technologies Inc. The Science of Melanotransferrin (p97) Notes from The Alzheimer’s Association’s Forum 2009 report b ...